Abstract
AbstractThe symposium will consist of current issues in genetic and environmental contributions to Parkinson's disease and other movement disorders with peer‐reviewed platform and poster presentations designed to communicate recent research advances, including new pharmacological and non‐pharmacological treatment options, in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other movement disorders thereby enhancing patient care.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have